Publication date: Jul 21, 2019
On the other hand, Bloombergreported Tuesday that DeepMind, the artificial-intelligence arm of Alphabet, might be on the cusp of a major breakthrough in the way new drugs are discovered.
Using data, machine learning and AI, Alphabet managers are incubating vibrant new businesses with innovative business models.
A Jefferies analyst pegged the value of Waymo, Alphabet’s self-driving-car business, at $250 billion in December 2018, according to a story at Business Insider.
Alphabet’s market capitalization is $798 billion, with units including YouTube, Google Search, Google Cloud, Android, the Nest security camera and peripheral businesses, Google Capital, and Stadia, its new video game streaming service set to launch in November.
Alphabet acquired the business in 2014.
Two years later, its custom AlphaGo code was so advanced that it became the first computer program to defeat a human in a match of Go, the ancient Chinese strategy game.
Despite its limited experience with folding, AlphaFold, DeepMind’s entrant, predicted the most accurate structure for 25 out of 43 proteins, taking the top spot over 98 participating teams, according to a report in the Guardian.
This does not mean Alphabet has an inside track to the next big drug discovery.
DeepMind has come out of nowhere to be a major player in that ecosystem, and it is hiding inside Alphabet shares, practically for free.
These metrics reflect the consensus view that Alphabet is an advertising business, subject to regulatory attacks.
- BlackThorn Therapeutics Secures $76 Million To Develop AI-Based Personalized Medicine For Mental Health
- i2b2 tranSMART Foundation Harvard Symposium 2019 – Personalized Medicine
- Pathology Machine Learning in Practice: Clinical trial and translational research applications
- Big Data vs. Big Disease: How Algorithms Can Stop Pandemics | Wendy Taylor
- Physician viewpoint: Precision medicine is a ‘great deal,’ regardless of cost
- Emma Huang, J&J Innovation – 2019 Stanford Medicine Big Data | Precision Health
- Don Rucker, HHS – 2019 Stanford Medicine Big Data | Precision Health
- Cigna Ventures leads $23M funding round in precision medicine company GNS Healthcare
- Jonathan Wilt, innovationOchsner – 2019 Stanford Medicine Big Data | Precision Health
- How Millennial Doctors Are Transforming Medicine
- Google, UChicago Medicine Sued Over Patient Data Sharing
- As ‘Precision Medicine’ Starts to Take Off, Here’s Who’s Poised to Capitalize
- Building the case for actionable ethics in digital health research supported by artificial intelligence.
- S17.3 The NIH All of us program: Building a national research program to advance precision medicine
- Marzyeh Ghassemi, University of Toronto – 2019 Stanford Medicine Big Data | Precision Health